Cite
MLA Citation
Wenbin Song et al.. “Targeting newly identified ERβ/TGF‐β1/SMAD3 signals with the FDA‐approved anti‐estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.” Molecular oncology, vol. 12, no. 12, 2018, pp. 2055–2071. http://access.bl.uk/ark:/81055/vdc_100073684290.0x000010